NDUFS3 and metabolic syndrome: Additionally, there was an increase in the expressions of NDUFS3 (1.8-fold of control), SDHA (3.5-fold of control), UQCRC2 (2.2-fold of control), COX-2 in (3.7-fold of control) and ATPB (3.6-fold of control) in the MetS + OVX group.